LQDA Q3 2018 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$169,730-90.7% YoY

Gross Profit

$169,730100.0% margin

Operating Income

-$9M-5462.1% margin

Net Income

-$10M-5699.1% margin

EPS (Diluted)

$-0.83

QoQ Revenue Growth

-83.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$864,352

Balance Sheet

Total Assets

$57M

Total Liabilities

$29M

Stockholders' Equity

$28M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$169,730	$2M	-90.7%
Gross Profit	$169,730	$2M	-90.3%
Operating Income	-$9M	-$8M	-18.9%
Net Income	-$10M	-$19M	+49.7%

Revenue Segments

Collaboration And Licensing Non Refundable Upfront Payments

$1M84%

Research And Development Services

$169,73012%

Collaboration And Licensing Milestones

$45,0583%